Strs Ohio Bio Atla, Inc. Transaction History

Strs Ohio

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 24, 2022	SELL	$19.0 - $30.95 $70,300 - $114,515	-3,700 Closed	0 $0
Q3 2021 Oct 22, 2021	BUY	$29.44 - $43.74 $17,664 - $26,244	600 Added 19.35%	3,700 $108,000
Q2 2021 Jul 26, 2021	BUY	$38.07 - $56.17 $11,421 - $16,851	300 Added 10.71%	3,100 $131,000
Q1 2021 Apr 23, 2021	BUY	$32.41 - $70.91 $90,747 - $198,548	2,800 New	2,800 $142,000

22.1M

10.7K

7.4K

Ticker BCAB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,304,100
Market Cap $59.2M
Description
BioAtla, Inc., a clinical stage biopharmaceutical company, develops specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Its lead product candidate is BA3011, a conditionally active biologic (CAB) antibody-drug conjugate (ADC) for soft tissue and bone sarcoma tumors, non-small cell lung cancer (NSCLC), and ...

Get notified when there are updates to the investment portfolio of Strs Ohio, based on Form 13F filings with the SEC.

Stay updated on Strs Ohio with notifications on news.